Clinical Trial Update: In-practice Evaluation of Atacand 16mg Antihypertensive Effect

View source ↗

Summary

The document notes the completion of a real-world evaluation of Atacand 16 mg for essential hypertension to assess its antihypertensive effect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Essential Hypertension | Status: COMPLETED